Sign in Subscribe
Health care industry

Fitch Ratings Affirms UnitedHealth Group's Ratings, with Negative Outlook

Strategic Insights

— 1 min read

UnitedHealth Group's financial performance has deteriorated significantly in 2025, driven by unexpectedly high trends in healthcare costs, leading to a weakening of its operating performance. The company's capitalization and leverage metrics are under pressure, with debt/EBITDA estimated to be approximately 2.7x in 2025, up from 2.0x in 2024. Fitch has revised its rating outlook to Negative from Stable, reflecting the company's diminished operating performance and potential downgrade sensitivities.

Key Takeaways:

  • UnitedHealth Group's insurance company subsidiaries have been affirmed with an 'AA-' (Very Strong) Insurer Financial Strength rating.
  • The Long-Term Issuer Default Rating (IDR) and senior unsecured notes have been affirmed at 'A'.
  • UnitedHealthCare Services, Inc.'s (UHS) IDR has been affirmed at 'A'.
  • The company's financial performance has weakened due to high healthcare costs, leading to a decline in operating margins and profitability.
  • Financial leverage metrics have consistently been in line with rating sensitivities over the past decade but are likely to remain above guidelines in 2025.
  • Fitch estimates that debt/EBITDA will be approximately 2.7x in 2025, up from 2.0x in 2024.
  • The company's capitalization remains supportive of its current ratings, and Fitch believes UnitedHealth has the willingness and ability to provide financial support to its operating company subsidiaries.
  • Emerging headwinds, including ongoing elevated healthcare utilization trends and a Department of Justice investigation, may challenge UnitedHealth's margin recovery efforts.
  • The company's credit profile benefits from significant cash flows derived from its Optum businesses, which are less heavily regulated than health insurance.

Statistics:

  • Operating EBITDA margin is expected to be approximately 6.5% in 2025, down from 9.8% in 2024.
  • Financial leverage ratio (FLR) is expected to be approximately 43% at year-end 2025.
  • NAIC RBC ratio was 230% of the company action level at year-end 2024, below guidelines for the current rating category but within management's stated target.
  • Debt/EBITDA is estimated to be approximately 2.7x in 2025, up from 2.0x in 2024.

Sources:

  • Fitch Ratings ("Fitch Affirms UnitedHealth Group's Ratings with Negative Outlook", July 30, 2025)
  • UnitedHealth Group (U.S. Securities and Exchange Commission filing, July 29, 2025)

Read more